News

Published on 12 Nov 2021 on Benzinga

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled...


Article preview image

Here's a roundup of top developments in the biotech space over the last 24 hours.

Johnson & Johnson (NYSE: JNJ) announced its intent to separate its Consumer Health business, creating a new publicly traded company. Following the planned separation, the new Johnson & Johnson would remain a diverse health care company and continue its commitment to lead in global healthcare R&D and innovation, with a portfolio that blends its strong Pharmaceutical and Medical Device capabilities.

NASDAQ.VIR price evolution
NASDAQ.GH price evolution
NASDAQ.ADPT price evolution
NASDAQ.AFIB price evolution
NYSE.ANVS price evolution
NASDAQ.ONCS price evolution
NASDAQ.ITRM price evolution
NYSE.EBS price evolution
NYSE.NVO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's...

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's...

Investing.com 7 Mar 2024

Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results

Total Revenues: Q4 2023 total revenues were $276.6 million, a 16% decrease from Q4 2022.Net Loss:...

GuruFocus.com via Yahoo Finance 7 Mar 2024

Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript

Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript March 6, 2024 Emergent Bio...

Insider Monkey via Yahoo Finance 7 Mar 2024

Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales

Emergent BioSolutions EBS reported an adjusted loss of 77 cents per share in fourth-quarter 2023,...

Zacks via Yahoo Finance 7 Mar 2024

Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement - Emergent BioSolutions (NYSE:EBS)

Emergent Biosolutions Inc EBS shares are trading higher after the company amended its existing cr...

Benzinga 6 Mar 2024

Emergent BioSolutions Inc. (NYSE:EBS) Q3 2023 Earnings Call Transcript

Emergent BioSolutions Inc. (NYSE:EBS) Q3 2023 Earnings Call Transcript November 8, 2023 Operator:...

Insider Monkey via Yahoo Finance 9 Nov 2023

Emergent BioSolutions Inc. (NYSE:EBS) institutional owners may be pleased with recent gains after...

Key Insights Institutions' substantial holdings in Emergent BioSolutions implies that they have s...

Simply Wall St. via Yahoo Finance 9 Nov 2023

Door Dash toughens its rules as college students return - The Boston Globe

Just in time for back-to-school season, delivery company DoorDash has put in place a number of ne...

The Boston Globe 30 Aug 2023

Narcan will be available for purchase over-the-counter in September. Here's what parents need to...

Where can parents find Narcan? Narcan (Naloxone HCl Nasal Spray 4 mg) will be available for purch...

Yahoo Life Style via AOL 30 Aug 2023

Overdose reversal drug Narcan will be available to buy over-the-counter starting in September

The overdose reversal drug Narcan will be available for over-the-counter purchase starting in...

ABC News via Yahoo News 30 Aug 2023